Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Neuland Labs Q4 Result: Profit surges 7x to ₹213 crore as export orders drive strong quarter
Neuland Laboratories net profit jumps sevenfold to ₹213 crore as revenue and margins surge on strong US and Europe exports, announces major capacity expansion and ₹34 rupee final dividend.
Dr Reddy's Q4 results 2026: Profit plunges 86% YoY to ₹220 crore; board recommends a final dividend of ₹8
Dr Reddy's Q4 results 2026: Dr Reddy's Laboratories reported a sharp 86.2% YoY fall in its consolidated net profit to ₹220.1 crore for Q4FY26. The company's board recommended a final dividend of ₹8 per share of face value of ₹1 each for FY26.
Unique Picks: 6 stocks held by only one MF scheme in April, falling up to 40% in CY26
An analysis of mutual fund portfolios revealed 29 stocks held exclusively by single schemes, with most underperforming in CY26. However, Satin Creditcare Network, Rossell Techsys, and Amanta Healthcare bucked the trend, delivering strong returns. Brooks Laboratories and EFC (I) were among those experiencing significant declines.
₹656 Dividend Bonanza: 71,000 retail shareholders of this MNC drugmaker set for their highest payout
This is the highest dividend payout on record for Abbott India, having surpassed the ₹475 per share it had paid shareholders last year.
Bajaj Healthcare reports Q4 net loss of ₹22.9 crore, recommends final dividend
Revenue slips marginally year-on-year, while EBITDA and margins improve sharply in the March quarter
Biocon reports 63% YoY fall in Q4 profit, final dividend of Rs. 0.50 recommended
Biocon's fourth-quarter net profit saw a significant drop of 63 percent year-on-year. This decline was attributed to exceptional charges impacting the company's financials. However, core businesses demonstrated growth. The company successfully integrated its biosimilars and generics operations. This strategic move aims to enhance scale and market reach. Biocon is now focused on improving profitability and creating long-term value for shareholders.
Lupin Shares Slump Despite 90% Jump In Q4 Profit, Highest-Ever Dividend Announcement
Of the 40 analysts tracing the stock as per Bloomberg data, Lupin has 'buy' calls from 28 of them. The stock also has eight 'hold' calls, and four 'sell' calls.
Biocon shares gain 3% despite 57% drop in Q4 profit; dividend announced
Bengaluru-based Biocon said that its Q4 profit stood at ₹198.6. The profit was hit by an exceptional item outgo of ₹80.4 crore on various heads, including the impact of the new labour code.
Lupin Q4 Results: Profit Soars 90%, Revenue Nears Rs 7,500 Crore; Highest-Ever Dividend Declared
Consolidated revenue of Lupin advanced by 31.9% year-on-year for the three months ended March, reaching Rs 7,475 crore in comparison to Rs 5,667 crore.
Dividend alert! Last date to buy these 10 stocks before they go ex-record date. Do you own?
Investors have a final opportunity today to purchase shares of 10 companies before they go ex-record date for dividends tomorrow, May 8. Notable companies include Central Bank of India, Laurus Labs, NALCO, and Premier Energies, with dividend payouts varying across the listed firms.
Blue Star Q4 Results: Net Profit Rises 17%, Dividend Declared — Check Record Date
Consolidate revenue of Blue Star advanced by 1.3% year-on-year for the three months ended March, reaching Rs 4,072 crore in comparison to Rs 4,019 crore.
Blue Star beats the Street, declares ₹8.5 dividend as net profit surges 17%
Shares of Blue Star Ltd ended at ₹1,807.35, up by ₹4.95, or 0.27%, on the BSE.